The Analyte Behind a Positive Whole-Blood Cannabinoid Screen

A positive whole-blood cannabinoid screen in this inhalation study was not a direct quantitative measurement of parent THC. The ELISA used a THCCOOH-based cutoff and responded to more than one cannabinoid.

The screen and the quantitative assay measured differently

In seventeen adults who had not used cannabis in the preceding month, researchers collected whole blood after smoked and vaporized cannabis. The blood ELISA used a cutoff of 10 ng/mL for THCCOOH, a THC metabolite.

The paper separately reported manufacturer-described cross-reactivity, including response to parent THC. The accompanying liquid chromatography–tandem mass spectrometry analysis quantified THC, 11-OH-THC, THCCOOH and THCCOOH-glucuronide individually. A screening classification and those compound-specific concentrations were different outputs.

The cutoff label matters

Calling the screening cutoff “10 ng/mL THC” would change the analyte named by the method. Nor can a positive screen be converted directly into an exact concentration of parent THC when several compounds can contribute to its response.

Interpretation should retain the specimen matrix, target calibrator, cross-reactivity information and confirmation procedure. An oral-fluid or urine screen may have a different target and different analytical characteristics even when all are described informally as cannabis tests.

Detection and impairment remain separate

The study’s concentrations did not yield a single reliable indicator of behavioral impairment. The pharmacokinetic paper and its companion acute-effects report also describe the same participant experiment, not independent replications. The useful first question is what the positive screen actually represents before drawing conclusions about functioning.

Related analysis: blood and oral-fluid patterns after inhaled cannabis.

Research cited

Spindle and colleagues (2019), Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid. DOI: 10.1093/jat/bky104.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Minor Breath Cannabinoids Were Not Detected in Every Early Sample

CBC and THCV showed promising early detection patterns, but neither was detected in every evaluated participant within the first hour. Their individual findings should not inherit the combined test’s reported 100% classification result. The marker counts were specific In the report’s table, CBC was detected in thirty-nine of forty participants…

Spread the love

Read Article: Minor Breath Cannabinoids Were Not Detected in Every Early Sample

Breath THC Half-Life Estimates Changed With the Sampling Interval

The reported breath THC half-life was much shorter immediately after smoking than at later sampling intervals. A two-point breath estimate was not a fixed whole-body elimination half-life. Different portions of the decline produced different values The report gave an average estimate of approximately 4.2 minutes over the zero-to-twenty-minute interval, compared…

Spread the love

Read Article: Breath THC Half-Life Estimates Changed With the Sampling Interval

Six-Month Frozen Pad Stability Did Not Mean Six-Month Breath Detection

The six-month experiment tested cannabinoids stored on fortified collection pads after preparation for laboratory evaluation. It did not test how long a living person continues to exhale cannabinoids after use. The study followed a collected material Fortified pads at low and high control concentrations were stored at −20°C. After six…

Spread the love

Read Article: Six-Month Frozen Pad Stability Did Not Mean Six-Month Breath Detection

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us